Monoclonal Antibody Biologics and BiosimilarsMarket, Global Outlook and Forecast 2025-2032

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Monoclonal Antibody Biologics and Biosimilars
1.2 Key Market Segments
1.2.1 Monoclonal Antibody Biologics and Biosimilars Segment by Type
1.2.2 Monoclonal Antibody Biologics and Biosimilars Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Monoclonal Antibody Biologics and Biosimilars Market Overview
2.1 Global Market Overview
2.1.1 Global Monoclonal Antibody Biologics and Biosimilars Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Monoclonal Antibody Biologics and Biosimilars Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Monoclonal Antibody Biologics and Biosimilars Market Competitive Landscape
3.1 Global Monoclonal Antibody Biologics and Biosimilars Sales by Manufacturers (2019-2025)
3.2 Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Manufacturers (2019-2025)
3.3 Monoclonal Antibody Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Monoclonal Antibody Biologics and Biosimilars Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Monoclonal Antibody Biologics and Biosimilars Sales Sites, Area Served, Product Type
3.6 Monoclonal Antibody Biologics and Biosimilars Market Competitive Situation and Trends
3.6.1 Monoclonal Antibody Biologics and Biosimilars Market Concentration Rate
3.6.2 Global 5 and 10 Largest Monoclonal Antibody Biologics and Biosimilars Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Monoclonal Antibody Biologics and Biosimilars Industry Chain Analysis
4.1 Monoclonal Antibody Biologics and Biosimilars Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Monoclonal Antibody Biologics and Biosimilars Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Monoclonal Antibody Biologics and Biosimilars Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Type (2019-2025)
6.3 Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2019-2025)
6.4 Global Monoclonal Antibody Biologics and Biosimilars Price by Type (2019-2025)
7 Monoclonal Antibody Biologics and Biosimilars Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Monoclonal Antibody Biologics and Biosimilars Market Sales by Application (2019-2025)
7.3 Global Monoclonal Antibody Biologics and Biosimilars Market Size (M USD) by Application (2019-2025)
7.4 Global Monoclonal Antibody Biologics and Biosimilars Sales Growth Rate by Application (2019-2025)
8 Monoclonal Antibody Biologics and Biosimilars Market Consumption by Region
8.1 Global Monoclonal Antibody Biologics and Biosimilars Sales by Region
8.1.1 Global Monoclonal Antibody Biologics and Biosimilars Sales by Region
8.1.2 Global Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Region
8.2 North America
8.2.1 North America Monoclonal Antibody Biologics and Biosimilars Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Monoclonal Antibody Biologics and Biosimilars Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Monoclonal Antibody Biologics and Biosimilars Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Monoclonal Antibody Biologics and Biosimilars Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Monoclonal Antibody Biologics and Biosimilars Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Monoclonal Antibody Biologics and Biosimilars Market Production by Region
9.1 Global Production of Monoclonal Antibody Biologics and Biosimilars by Region (2019-2025)
9.2 Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Region (2019-2025)
9.3 Global Monoclonal Antibody Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Monoclonal Antibody Biologics and Biosimilars Production
9.4.1 North America Monoclonal Antibody Biologics and Biosimilars Production Growth Rate (2019-2025)
9.4.2 North America Monoclonal Antibody Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Monoclonal Antibody Biologics and Biosimilars Production
9.5.1 Europe Monoclonal Antibody Biologics and Biosimilars Production Growth Rate (2019-2025)
9.5.2 Europe Monoclonal Antibody Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Monoclonal Antibody Biologics and Biosimilars Production (2019-2025)
9.6.1 Japan Monoclonal Antibody Biologics and Biosimilars Production Growth Rate (2019-2025)
9.6.2 Japan Monoclonal Antibody Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Monoclonal Antibody Biologics and Biosimilars Production (2019-2025)
9.7.1 China Monoclonal Antibody Biologics and Biosimilars Production Growth Rate (2019-2025)
9.7.2 China Monoclonal Antibody Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Roche
10.1.1 Roche Monoclonal Antibody Biologics and Biosimilars Basic Information
10.1.2 Roche Monoclonal Antibody Biologics and Biosimilars Product Overview
10.1.3 Roche Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche Monoclonal Antibody Biologics and Biosimilars SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Amgen
10.2.1 Amgen Monoclonal Antibody Biologics and Biosimilars Basic Information
10.2.2 Amgen Monoclonal Antibody Biologics and Biosimilars Product Overview
10.2.3 Amgen Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen Monoclonal Antibody Biologics and Biosimilars SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 AbbVie
10.3.1 AbbVie Monoclonal Antibody Biologics and Biosimilars Basic Information
10.3.2 AbbVie Monoclonal Antibody Biologics and Biosimilars Product Overview
10.3.3 AbbVie Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.3.4 AbbVie Monoclonal Antibody Biologics and Biosimilars SWOT Analysis
10.3.5 AbbVie Business Overview
10.3.6 AbbVie Recent Developments
10.4 Sanofi
10.4.1 Sanofi Monoclonal Antibody Biologics and Biosimilars Basic Information
10.4.2 Sanofi Monoclonal Antibody Biologics and Biosimilars Product Overview
10.4.3 Sanofi Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Johnson and Johnson
10.5.1 Johnson and Johnson Monoclonal Antibody Biologics and Biosimilars Basic Information
10.5.2 Johnson and Johnson Monoclonal Antibody Biologics and Biosimilars Product Overview
10.5.3 Johnson and Johnson Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.5.4 Johnson and Johnson Business Overview
10.5.5 Johnson and Johnson Recent Developments
10.6 Pfizer
10.6.1 Pfizer Monoclonal Antibody Biologics and Biosimilars Basic Information
10.6.2 Pfizer Monoclonal Antibody Biologics and Biosimilars Product Overview
10.6.3 Pfizer Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Eli Lilly
10.7.1 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Basic Information
10.7.2 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product Overview
10.7.3 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.7.4 Eli Lilly Business Overview
10.7.5 Eli Lilly Recent Developments
10.8 Novartis
10.8.1 Novartis Monoclonal Antibody Biologics and Biosimilars Basic Information
10.8.2 Novartis Monoclonal Antibody Biologics and Biosimilars Product Overview
10.8.3 Novartis Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.8.4 Novartis Business Overview
10.8.5 Novartis Recent Developments
10.9 Merck
10.9.1 Merck Monoclonal Antibody Biologics and Biosimilars Basic Information
10.9.2 Merck Monoclonal Antibody Biologics and Biosimilars Product Overview
10.9.3 Merck Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.9.4 Merck Business Overview
10.9.5 Merck Recent Developments
10.10 Biogen
10.10.1 Biogen Monoclonal Antibody Biologics and Biosimilars Basic Information
10.10.2 Biogen Monoclonal Antibody Biologics and Biosimilars Product Overview
10.10.3 Biogen Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.10.4 Biogen Business Overview
10.10.5 Biogen Recent Developments
10.11 Celltrion
10.11.1 Celltrion Monoclonal Antibody Biologics and Biosimilars Basic Information
10.11.2 Celltrion Monoclonal Antibody Biologics and Biosimilars Product Overview
10.11.3 Celltrion Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.11.4 Celltrion Business Overview
10.11.5 Celltrion Recent Developments
10.12 Sobi
10.12.1 Sobi Monoclonal Antibody Biologics and Biosimilars Basic Information
10.12.2 Sobi Monoclonal Antibody Biologics and Biosimilars Product Overview
10.12.3 Sobi Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.12.4 Sobi Business Overview
10.12.5 Sobi Recent Developments
10.13 3SBIO
10.13.1 3SBIO Monoclonal Antibody Biologics and Biosimilars Basic Information
10.13.2 3SBIO Monoclonal Antibody Biologics and Biosimilars Product Overview
10.13.3 3SBIO Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.13.4 3SBIO Business Overview
10.13.5 3SBIO Recent Developments
10.14 Innovent Biologics
10.14.1 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Basic Information
10.14.2 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product Overview
10.14.3 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product Market Performance
10.14.4 Innovent Biologics Business Overview
10.14.5 Innovent Biologics Recent Developments
11 Monoclonal Antibody Biologics and Biosimilars Market Forecast by Region
11.1 Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast
11.2 Global Monoclonal Antibody Biologics and Biosimilars Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Country
11.2.3 Asia Pacific Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Region
11.2.4 South America Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Monoclonal Antibody Biologics and Biosimilars by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Monoclonal Antibody Biologics and Biosimilars Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Monoclonal Antibody Biologics and Biosimilars by Type (2025-2032)
12.1.2 Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Monoclonal Antibody Biologics and Biosimilars by Type (2025-2032)
12.2 Global Monoclonal Antibody Biologics and Biosimilars Market Forecast by Application (2025-2032)
12.2.1 Global Monoclonal Antibody Biologics and Biosimilars Sales (K MT) Forecast by Application
12.2.2 Global Monoclonal Antibody Biologics and Biosimilars Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Monoclonal Antibody Biologics and Biosimilars Market Size Comparison by Region (M USD)
Table 5. Global Monoclonal Antibody Biologics and Biosimilars Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Monoclonal Antibody Biologics and Biosimilars Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Monoclonal Antibody Biologics and Biosimilars Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Biologics and Biosimilars as of 2022)
Table 10. Global Market Monoclonal Antibody Biologics and Biosimilars Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Monoclonal Antibody Biologics and Biosimilars Sales Sites and Area Served
Table 12. Manufacturers Monoclonal Antibody Biologics and Biosimilars Product Type
Table 13. Global Monoclonal Antibody Biologics and Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Monoclonal Antibody Biologics and Biosimilars
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Monoclonal Antibody Biologics and Biosimilars Market Challenges
Table 22. Global Monoclonal Antibody Biologics and Biosimilars Sales by Type (K MT)
Table 23. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Type (M USD)
Table 24. Global Monoclonal Antibody Biologics and Biosimilars Sales (K MT) by Type (2019-2025)
Table 25. Global Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Type (2019-2025)
Table 26. Global Monoclonal Antibody Biologics and Biosimilars Market Size (M USD) by Type (2019-2025)
Table 27. Global Monoclonal Antibody Biologics and Biosimilars Market Size Share by Type (2019-2025)
Table 28. Global Monoclonal Antibody Biologics and Biosimilars Price (USD/MT) by Type (2019-2025)
Table 29. Global Monoclonal Antibody Biologics and Biosimilars Sales (K MT) by Application
Table 30. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Application
Table 31. Global Monoclonal Antibody Biologics and Biosimilars Sales by Application (2019-2025) & (K MT)
Table 32. Global Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Application (2019-2025)
Table 33. Global Monoclonal Antibody Biologics and Biosimilars Sales by Application (2019-2025) & (M USD)
Table 34. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Application (2019-2025)
Table 35. Global Monoclonal Antibody Biologics and Biosimilars Sales Growth Rate by Application (2019-2025)
Table 36. Global Monoclonal Antibody Biologics and Biosimilars Sales by Region (2019-2025) & (K MT)
Table 37. Global Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Region (2019-2025)
Table 38. North America Monoclonal Antibody Biologics and Biosimilars Sales by Country (2019-2025) & (K MT)
Table 39. Europe Monoclonal Antibody Biologics and Biosimilars Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Monoclonal Antibody Biologics and Biosimilars Sales by Region (2019-2025) & (K MT)
Table 41. South America Monoclonal Antibody Biologics and Biosimilars Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Monoclonal Antibody Biologics and Biosimilars Sales by Region (2019-2025) & (K MT)
Table 43. Global Monoclonal Antibody Biologics and Biosimilars Production (K MT) by Region (2019-2025)
Table 44. Global Monoclonal Antibody Biologics and Biosimilars Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Region (2019-2025)
Table 46. Global Monoclonal Antibody Biologics and Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Monoclonal Antibody Biologics and Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Monoclonal Antibody Biologics and Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Monoclonal Antibody Biologics and Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Monoclonal Antibody Biologics and Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Roche Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 52. Roche Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 53. Roche Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Roche Business Overview
Table 55. Roche Monoclonal Antibody Biologics and Biosimilars SWOT Analysis
Table 56. Roche Recent Developments
Table 57. Amgen Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 58. Amgen Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 59. Amgen Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Amgen Business Overview
Table 61. Amgen Monoclonal Antibody Biologics and Biosimilars SWOT Analysis
Table 62. Amgen Recent Developments
Table 63. AbbVie Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 64. AbbVie Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 65. AbbVie Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. AbbVie Monoclonal Antibody Biologics and Biosimilars SWOT Analysis
Table 67. AbbVie Business Overview
Table 68. AbbVie Recent Developments
Table 69. Sanofi Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 70. Sanofi Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 71. Sanofi Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Sanofi Business Overview
Table 73. Sanofi Recent Developments
Table 74. Johnson and Johnson Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 75. Johnson and Johnson Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 76. Johnson and Johnson Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Johnson and Johnson Business Overview
Table 78. Johnson and Johnson Recent Developments
Table 79. Pfizer Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 80. Pfizer Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 81. Pfizer Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Pfizer Business Overview
Table 83. Pfizer Recent Developments
Table 84. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 85. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 86. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Recent Developments
Table 89. Novartis Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 90. Novartis Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 91. Novartis Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Novartis Business Overview
Table 93. Novartis Recent Developments
Table 94. Merck Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 95. Merck Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 96. Merck Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Merck Business Overview
Table 98. Merck Recent Developments
Table 99. Biogen Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 100. Biogen Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 101. Biogen Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Biogen Business Overview
Table 103. Biogen Recent Developments
Table 104. Celltrion Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 105. Celltrion Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 106. Celltrion Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Celltrion Business Overview
Table 108. Celltrion Recent Developments
Table 109. Sobi Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 110. Sobi Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 111. Sobi Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Sobi Business Overview
Table 113. Sobi Recent Developments
Table 114. 3SBIO Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 115. 3SBIO Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 116. 3SBIO Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. 3SBIO Business Overview
Table 118. 3SBIO Recent Developments
Table 119. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Basic Information
Table 120. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product Overview
Table 121. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Innovent Biologics Business Overview
Table 123. Innovent Biologics Recent Developments
Table 124. Global Monoclonal Antibody Biologics and Biosimilars Sales Forecast by Region (2025-2032) & (K MT)
Table 125. Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Monoclonal Antibody Biologics and Biosimilars Sales Forecast by Country (2025-2032) & (K MT)
Table 127. North America Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Monoclonal Antibody Biologics and Biosimilars Sales Forecast by Country (2025-2032) & (K MT)
Table 129. Europe Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Monoclonal Antibody Biologics and Biosimilars Sales Forecast by Region (2025-2032) & (K MT)
Table 131. Asia Pacific Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Monoclonal Antibody Biologics and Biosimilars Sales Forecast by Country (2025-2032) & (K MT)
Table 133. South America Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Monoclonal Antibody Biologics and Biosimilars Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Monoclonal Antibody Biologics and Biosimilars Sales Forecast by Type (2025-2032) & (K MT)
Table 137. Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Monoclonal Antibody Biologics and Biosimilars Price Forecast by Type (2025-2032) & (USD/MT)
Table 139. Global Monoclonal Antibody Biologics and Biosimilars Sales (K MT) Forecast by Application (2025-2032)
Table 140. Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Monoclonal Antibody Biologics and Biosimilars
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Monoclonal Antibody Biologics and Biosimilars Market Size (M USD), 2019-2032
Figure 5. Global Monoclonal Antibody Biologics and Biosimilars Market Size (M USD) (2019-2032)
Figure 6. Global Monoclonal Antibody Biologics and Biosimilars Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Monoclonal Antibody Biologics and Biosimilars Market Size by Country (M USD)
Figure 11. Monoclonal Antibody Biologics and Biosimilars Sales Share by Manufacturers in 2023
Figure 12. Global Monoclonal Antibody Biologics and Biosimilars Revenue Share by Manufacturers in 2023
Figure 13. Monoclonal Antibody Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Monoclonal Antibody Biologics and Biosimilars Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Monoclonal Antibody Biologics and Biosimilars Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Type
Figure 18. Sales Market Share of Monoclonal Antibody Biologics and Biosimilars by Type (2019-2025)
Figure 19. Sales Market Share of Monoclonal Antibody Biologics and Biosimilars by Type in 2023
Figure 20. Market Size Share of Monoclonal Antibody Biologics and Biosimilars by Type (2019-2025)
Figure 21. Market Size Market Share of Monoclonal Antibody Biologics and Biosimilars by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Application
Figure 24. Global Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Application (2019-2025)
Figure 25. Global Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Application in 2023
Figure 26. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Application (2019-2025)
Figure 27. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Application in 2023
Figure 28. Global Monoclonal Antibody Biologics and Biosimilars Sales Growth Rate by Application (2019-2025)
Figure 29. Global Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Region (2019-2025)
Figure 30. North America Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Country in 2023
Figure 32. U.S. Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Monoclonal Antibody Biologics and Biosimilars Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Monoclonal Antibody Biologics and Biosimilars Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Country in 2023
Figure 37. Germany Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Region in 2023
Figure 44. China Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (K MT)
Figure 50. South America Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Country in 2023
Figure 51. Brazil Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Monoclonal Antibody Biologics and Biosimilars Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Monoclonal Antibody Biologics and Biosimilars Production Market Share by Region (2019-2025)
Figure 62. North America Monoclonal Antibody Biologics and Biosimilars Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Monoclonal Antibody Biologics and Biosimilars Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Monoclonal Antibody Biologics and Biosimilars Production (K MT) Growth Rate (2019-2025)
Figure 65. China Monoclonal Antibody Biologics and Biosimilars Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Monoclonal Antibody Biologics and Biosimilars Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Monoclonal Antibody Biologics and Biosimilars Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Monoclonal Antibody Biologics and Biosimilars Market Share Forecast by Type (2025-2032)
Figure 70. Global Monoclonal Antibody Biologics and Biosimilars Sales Forecast by Application (2025-2032)
Figure 71. Global Monoclonal Antibody Biologics and Biosimilars Market Share Forecast by Application (2025-2032)

DOWNLOAD SAMPLE